Source link : https://www.newshealth.biz/health-news/emapalumab-effective-in-rheumatologic-disease-associated-hlh/
TOPLINE: Emapalumab (Gamifant)-containing regimens stabilize key laboratory parameters and show a high 12-month survival probability in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis (HLH). METHODOLOGY: Researchers conducted a retrospective medical chart review study across 33 US hospitals to assess the real-world treatment patterns and outcomes in patients with HLH treated with emapalumab. They included 15 patients […]
Author : News Health
Publish date : 2024-09-26 07:11:12
Copyright for syndicated content belongs to the linked Source.